Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewan Forrest

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
BMJ Open|April 7, 2016
Health and social consequences of an alcohol-related admission to critical care: a qualitative studyJoanne McPeake, Ewan Forrest, Tara Quasim, et al.
Clinical and Translational Gastroenterology|April 5, 2023
Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated CirrhosisTope Oyelade, Ewan Forrest, Kevin P Moore, et al.
NIHR Open Research|December 11, 2024
The Scottish Hepatology Access Research Partnership (SHARP) improving access to liver services throughout ScotlandRuairi Lynch, Jonathan Fallowfield, David Blane, et al.
Hepatology (Baltimore, Md.)|July 19, 2005
Grading alcoholic hepatitisEwan Forrest, Saket Singhal, Geoffrey Haydon, et al.
The American Journal of Gastroenterology|September 14, 2021
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE TrialLouise China, Nick Freemantle, Ewan Forrest, et al.
Critical Care (London, England)|April 23, 2015
Do alcohol use disorders impact on long term outcomes from intensive care?Joanne M McPeake, Martin Shaw, Anna O'Neill, et al.
Journal of Critical Care|September 2, 2014
The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unitPhilip Emerson, Joanne McPeake, Anna O'Neill, et al.
Annals of Hepatology|July 3, 2025
Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRENikolaj Torp, Louise China, Mads Israelsen, et al.
Eclinicalmedicine|November 21, 2022
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trialThais Tittanegro, Louise China, Ewan Forrest, et al.
Eclinicalmedicine|April 24, 2023
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trialLouise China, Thais Tittanegro, Dominic Crocombe, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
BMJ Open|April 7, 2016
Health and social consequences of an alcohol-related admission to critical care: a qualitative studyJoanne McPeake, Ewan Forrest, Tara Quasim, et al.
Clinical and Translational Gastroenterology|April 5, 2023
Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated CirrhosisTope Oyelade, Ewan Forrest, Kevin P Moore, et al.
NIHR Open Research|December 11, 2024
The Scottish Hepatology Access Research Partnership (SHARP) improving access to liver services throughout ScotlandRuairi Lynch, Jonathan Fallowfield, David Blane, et al.
Hepatology (Baltimore, Md.)|July 19, 2005
Grading alcoholic hepatitisEwan Forrest, Saket Singhal, Geoffrey Haydon, et al.
The American Journal of Gastroenterology|September 14, 2021
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE TrialLouise China, Nick Freemantle, Ewan Forrest, et al.
Critical Care (London, England)|April 23, 2015
Do alcohol use disorders impact on long term outcomes from intensive care?Joanne M McPeake, Martin Shaw, Anna O'Neill, et al.
Journal of Critical Care|September 2, 2014
The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unitPhilip Emerson, Joanne McPeake, Anna O'Neill, et al.
Annals of Hepatology|July 3, 2025
Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRENikolaj Torp, Louise China, Mads Israelsen, et al.
Eclinicalmedicine|November 21, 2022
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trialThais Tittanegro, Louise China, Ewan Forrest, et al.
Eclinicalmedicine|April 24, 2023
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trialLouise China, Thais Tittanegro, Dominic Crocombe, et al.
Pageof 6